The authors discuss the assessment and treatment of pediatric ADHD within the framework of the cultural psychotherapeutic model.
What impact do atypical antipsychotic agents have on the persistence of stimulant therapy in ADHD? Researchers sought to find the answer in a group of 40,000 children and adolescents.
The rate of co-occurrence of ADHD and OCD has been reported to be as high as 60%. A question persists, however, on whether ADHD-OCD comorbidity is a true entity or whether symptoms attributed to one may be facets of a phenotype of the other.
The most common pesticide for residential use and increasingly used in agriculture may be encouraging expression of an ADHD phenotype.
Studies examining the impact of ADHD drugs on dopamine transport have been inconclusive, and preclinical research suggests that emotional factors play a greater role than stimulant therapy in fostering addictive behaviors.
Rates of severe mental illness in children and adolescents have dropped 16% since 1996, according to a new study. The lead author explains possible reasons for this surprising finding and concludes: "We're moving in the right direction!"
New national cohort prospective study finds increased, though rare, cardiovascular risks associated with stimulant use in children and adolescents with ADHD. Is your patient at risk?
What forces influence your decision to treat ADHD? Case vignettes and a back-to-basics approach may bring clarity to the diagnostic and therapeutic clinical processes that surround the decision.
Evidence suggests that co-occurrence with ADHD is a marker of preadolescent-onset mania. This slideshow provides some evidence for you to decide whether this form of very early-onset mania represents a developmental subtype of the disorder.
What factors are involved in parents’ decision to begin medication treatment for a child with ADHD? An overview of studies that provide clinically relevant information related to the course and treatment outcomes of ADHD in children and adolescents.